Janet Warrington

Senior Vice President
Cardiology
Centrillion Biosciences
United States of America

Business Expert Cardiology
Biography

    Dr. Warrington has more than 25 years of experience in biotechnology devices and diagnostics R&D. She began her scientific career at Affymetrix where she led development efforts focused on laying the foundation for genomics in the clinical laboratory. She led the first biotech consortium for the development of a genomics standard reference material, SRM 2374, and in partnership with Roche Molecular Systems, was the lead scientist for the first FDA cleared microarray system. In 2009, she co-founded Second Genome Inc., and in 2014 Janet joined Wei, Glenn, and the Centrillion team to build cutting-edge genomics technologies.  

Research Intrest

    Cardiology